Do you want to work in an innovative and meaningful environment where quality and development are in focus? We are looking for a driven and meticulous laboratory engineer to join our team in Solna.
Valneva’s vision is a world in which no one dies or suffers from a disease that can be prevented by vaccination. Valneva has several vaccines in development, including the world’s first chikungunya vaccine, the only Lyme borreliosis vaccine candidate in partnership with Pfizer, and candidates against other global health threats.
Valneva’s portfolio also includes two commercial vaccines for travelers: one against Japanese encephalitis and one against cholera. Valneva operates internationally across Austria, Sweden, the UK, France, Canada and the USA.
Valneva Sweden AB has a long history in Sweden and today operates from Solna.
Learn more at www.valneva.com.
As a Senior Laboratory Engineer within Quality Control, you will act as a technical expert in validation and qualification across the QC department. You will lead major change controls, improvement initiatives, and complex deviations, while supporting colleagues in quality-related activities and routine QC testing.
The role also includes delivering internal GMP training, providing technical guidance, and contributing to the continued development of QC processes and ways of working.
You are an experienced and quality-focused QC professional who takes ownership, works in a structured way, and enjoys solving complex technical issues. You are collaborative, confident in sharing your expertise, and comfortable supporting and coaching colleagues.
This is a permanent, full-time position based at our Solna site, with a six-month probationary period.
We believe collaboration is strongest when we meet in person while still offering flexibility. The role follows Valneva Sweden's hybrid working model, with at least 50% of working time spent on-site in Solna.
As part of Valneva, you will receive a competitive employment package under the applicable Swedish collective agreement, including:
You will join an international organisation where your work contributes to our mission of developing, manufacturing and commercialising vaccines that address unmet medical needs.
Application deadline: 7th of October.
We review applications and conduct interviews on an ongoing basis, so we encourage you to apply as soon as possible.
Please submit your CV and, where applicable, cover letter in English through our careers site.
For GDPR reasons, we are unable to accept or review applications sent by email.
Our recruitment process includes reference checks, a comprehensive background check and drug test for the final candidate.
For questions about the position or recruitment process, please contact HR.Sweden@valneva.com.
We respectfully decline contact from recruitment agencies, staffing companies and other suppliers regarding this recruitment.
Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs.
We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions.
We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines.
Revenues from our growing commercial business help fuel the continued advancement of our vaccine pipeline. This includes the only Lyme disease vaccine candidate in advanced clinical development, which is partnered with Pfizer, as well as vaccine candidates against the Zika virus and other global public health threats.
Valneva has operations in Austria, Sweden, the United Kingdom, France, Canada and the U.S. with approximately 700 employees.
